We are pleased to announce the completion of our Third-Party Allotment of New Shares (or simply Capital Increase) in the Seed Round 1st Close, raising a total of ¥150 million (JPY 150 million). For more details, please see this link. 投稿ナビゲーション Aiki Marushima, CEO of CrestecBio, Speaks as a Panelist at “Japan DeepTech Night”
